About this Journal Submit a Manuscript Table of Contents
Experimental Diabetes Research
Volume 2012 (2012), Article ID 745189, 5 pages
Clinical Study

Serum CA19-9 Level Associated with Metabolic Control and Pancreatic Beta Cell Function in Diabetic Patients

1School of Medicine, Shanghai Jiao Tong University, Shanghai 200233, China
2Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Diabetes Institute, Shanghai Clinical Center of Diabetes, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai 200233, China
3Department of medicine, Soochow University, Soochow 215006, China

Received 10 January 2012; Revised 15 March 2012; Accepted 15 April 2012

Academic Editor: Chien-Jen Chen

Copyright © 2012 Haoyong Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Y. Locker, S. Hamilton, J. Harris et al., “ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer,” Journal of Clinical Oncology, vol. 24, no. 33, pp. 5313–5327, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Pines, J. L. Slama, A. Holeman, G. Ley, D. Malbec, and P. Boudon, “Unusually high level of CA 19-9 in chronic pancreatitis,” Gastroenterologie Clinique et Biologique, vol. 19, no. 6-7, pp. 641–642, 1995. View at Scopus
  3. J. M. Petit, G. Vaillant, N. O. Olsson et al., “Elevated serum CA19-9 levels in poorly controlled diabetic patients. Relationship with Lewis blood group,” Gastroenterologie Clinique et Biologique, vol. 18, no. 1, pp. 17–20, 1994. View at Scopus
  4. H. Mukae, M. Hirota, S. Kohno et al., “Elevation of tumor-associated carbohydrate antigens in patients with diffuse panbronchiolitis,” American Review of Respiratory Disease, vol. 148, no. 3, pp. 744–751, 1993. View at Scopus
  5. P. Y. Benhamou, J. P. Vuillez, S. Halimi, G. Meffre, and I. Bachelot, “Influence of metabolic disturbances of diabetes mellitus on serum CA 19-9 tumor marker,” Diabete et Metabolisme, vol. 17, no. 1, pp. 39–43, 1991. View at Scopus
  6. K. Gul, S. Nas, D. Ozdemir, M. Gumus, R. Ersoy, and B. Cakir, “CA 19-9 level in patients with type 2 diabetes mellitus and its relation to the metabolic control and microvascular complications,” The American Journal of the Medical Sciences, vol. 341, no. 1, pp. 28–32, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. O. Uygur-Bayramicli, R. Dabak, E. Orbay, et al., “Type 2 diabetes mellitus and CA 19-9 levels,” World Journal of Gastroenterology, vol. 13, pp. 5357–5359, 2007.
  8. N. Nakamura, O. Aoji, and T. Yoshikawa, “Elevated serum CA19-9 levels in poorly controlled diabetic patients,” Japanese Journal of Medicine, vol. 25, no. 3, pp. 278–380, 1986. View at Scopus
  9. Y. Arakawa, H. Ariga, and M. Kano, “Determination and significance of a new carbohydrate antigen CA 19-9 in digestive system cancers,” Japanese Journal of Medicine, vol. 24, no. 2, pp. 121–130, 1985. View at Scopus
  10. J. A. Williams and I. D. Goldfine, “The insulin-pancreatic acinar axis,” Diabetes, vol. 34, no. 10, pp. 980–986, 1985. View at Scopus
  11. P. D. Hardt and N. Ewald, “Exocrine pancreatic insufficiency in diabetes mellitus: a complication of diabetic neuropathy or a different type of diabetes?” Experimental Diabetes Research, vol. 2011, Article ID 761950, 7 pages, 2011. View at Publisher · View at Google Scholar
  12. H. T. Blumenthal, J. G. Probstein, and A. W. Berns, “Interrelationship of diabetes mellitus and pancreatitis,” Archives of Surgery, vol. 87, pp. 844–850, 1963. View at Scopus
  13. C. Langhi and B. Cariou, “Cholesterol metabolism and beta-cell function,” Medecine/Sciences, vol. 26, no. 4, pp. 385–390, 2010. View at Scopus
  14. M. Ishikawa, Y. Iwasaki, S. Yatoh et al., “Cholesterol accumulation and diabetes in pancreatic β-cell-specific SREBP-2 transgenic mice: a new model for lipotoxicity,” Journal of Lipid Research, vol. 49, no. 12, pp. 2524–2534, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Hao, W. S. Head, S. C. Gunawardana, A. H. Hasty, and D. W. Piston, “Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic β-cell dysfunction,” Diabetes, vol. 56, no. 9, pp. 2328–2338, 2007. View at Publisher · View at Google Scholar · View at Scopus